4//SEC Filing
Spangler Patrick D 4
Accession 0001213900-21-059450
CIK 0001448431other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 4:45 PM ET
Size
4.6 KB
Accession
0001213900-21-059450
Insider Transaction Report
Form 4
OptimizeRx CorpOPRX
Spangler Patrick D
Director
Transactions
- Sale
Common Stock (pursuant to 10B5-1 plan)
2021-11-11$84.38/sh−6,252$527,544→ 16,083 total
Footnotes (1)
- [F1]These shares sold pursuant to a plan of disposition adopted on September 7, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Documents
Issuer
OptimizeRx Corp
CIK 0001448431
Entity typeother
Related Parties
1- filerCIK 0001296525
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 4:45 PM ET
- Size
- 4.6 KB